glp 1 effects on heart Cardiovascular of Glucagon-like peptide (GLP-1) receptor agonists | Cardiovascular Diabetology Exploring the Cardiovascular Effects of

Corxel Pharmaceuticals raises $287M Series D1 with new investors SR One, TCGX & RA Capital to advance oral GLP-1 program acquired from Vincentage & other pipeline assets.

Healthon connects patients with U

Women benefit most when we treat menopause as the metabolic inflection point it isnot just prescribing GLP-1s in isolation, but considering hormone therapy, addressing sleep disruption (which drives cortisol and undermines any weight loss effort), and building strength to counter the lean mass loss these medications can cause

researchers are exploring how these drugs may affect more than appetite, blood sugar, and weight loss

Dual- and multi-receptor agonists may be a novel drug class to treat obesity and type 2 diabetes mellitus with high efficacy.